Pharmacological validation of TDO as a target for Parkinson’s diseasePaula Perez‐Pardo, Aletta D. Kraneveld, Michaela Tutone et al.|FEBS Journal|2021Cited by 29
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020Jeffrey J. Kooijman, Guido J.R. Zaman, Wilhelmina E. van Riel et al.|Frontiers in Oncology|2022Cited by 22